Chemeq shares jump as first order shipped
Wednesday, 06 October, 2004
Chemeq shares jumped 46 per cent today after the company announced that it had shipped its first order of its polymeric anti-microbial product to South Africa for use in poultry.
"This marks the beginning," said the company in a statement to the market.
The product, which due to its priority was manufactured in Chemeq's APVMA-approved pilot facility, was an order in addition to a previously announced sale for AUD$1.5 million, which is conditional on the upcoming approval of the new manufacturing facility by the APVMA.
The company also announced that a US patent for manufacturing and marketing of Chemeq's product had been granted, extending the protection to 2020.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
